BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35245168)

  • 1. Decreased incremental shuttle walk test distance characterized by fibrocavitary lesions in non-tuberculous mycobacterial pulmonary disease.
    Ono K; Tabusadani M; Yamane K; Takao S; Mori K; Matsumura Y; Kuroyama Y; Kawahara K; Omatsu S; Furuuchi K; Fujiwara K; Morimoto K; Kimura H; Senjyu H
    Expert Rev Respir Med; 2022 Apr; 16(4):469-475. PubMed ID: 35245168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental Shuttle Walk Distance as an Indicator for Functional Exercise Capacity of Pre-Surgical Patients with Nontuberculous Mycobacterial Lung Disease.
    Kuroyama Y; Tabusadani M; Omatsu S; Shiraishi Y; Senjyu H
    Tohoku J Exp Med; 2020 Jan; 250(1):43-48. PubMed ID: 31996491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
    Billings CG; Lewis R; Hurdman JA; Condliffe R; Elliot CA; Thompson AAR; Smith IA; Austin M; Armstrong IJ; Hamilton N; Charalampopoulos A; Sabroe I; Swift AJ; Rothman AM; Wild JM; Lawrie A; Waterhouse JC; Kiely DG
    Pulm Circ; 2019; 9(2):2045894019848649. PubMed ID: 30997865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis.
    Kim H; Lee S; Kim JW; Jung JY; Suh CH; Kim HA
    Korean J Intern Med; 2024 Jan; 39(1):172-183. PubMed ID: 38031367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Determinants of Incremental Shuttle Walk Test in Adults with Bronchiectasis.
    Yildiz S; Inal-Ince D; Calik-Kutukcu E; Vardar-Yagli N; Saglam M; Arikan H; Coplu L
    Lung; 2018 Jun; 196(3):343-349. PubMed ID: 29435737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.
    Jhun BW; Moon SM; Jeon K; Kwon OJ; Yoo H; Carriere KC; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31619468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S; Kops S; Magis-Escurra C; Boeree MJ; van Ingen J; Hoefsloot W
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normative reference values, determinants and regression equations for the incremental shuttle walk test (ISWT) in healthy Asian population aged 21 to 80 years.
    Azman MZB; Huang KS; Koh WJ; Leong SS; Ong B; Soon JL; Tan SW; Chan MY; Yang M; Yeung MT
    PLoS One; 2023; 18(9):e0291132. PubMed ID: 37669286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference values for the incremental shuttle walk test in healthy subjects: from the walk distance to physiological responses.
    Dourado VZ; Guerra RL; Tanni SE; Antunes LC; Godoy I
    J Bras Pneumol; 2013; 39(2):190-7. PubMed ID: 23670504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease.
    Kawahara K; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Matsumura Y; Mori K; Ono K; Omatsu S; Furuuchi K; Fujiwara K; Morimoto K; Kimura H; Senjyu H
    Int J Tuberc Lung Dis; 2021 Apr; 25(4):299-304. PubMed ID: 33762074
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1.
    Pan SW; Su WJ; Chan YJ; Ho ML; Feng JY; Shu CC; Wang JY; Wang HC; Yu CJ; Chen YM
    Clin Infect Dis; 2022 Aug; 75(2):239-247. PubMed ID: 34726741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.
    Vande Weygaerde Y; Cardinaels N; Bomans P; Chin T; Boelens J; André E; Van Braeckel E; Lorent N
    BMC Infect Dis; 2019 Dec; 19(1):1061. PubMed ID: 31847834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia.
    Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M
    Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis.
    Park HY; Suh GY; Chung MP; Kim H; Kwon OJ; Chung MJ; Kim TS; Lee KS; Koh WJ
    J Korean Med Sci; 2009 Jun; 24(3):427-32. PubMed ID: 19543504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance and safety of combined treatment with chemotherapy and pulmonary rehabilitation regarding health-related quality of life and physical function in nontuberculous mycobacterial pulmonary disease.
    Omatsu S; Tabusadani M; Yamane K; Takao S; Kuroyama Y; Matsumura Y; Mori K; Ono K; Kawahara K; Senjyu H; Kozu R
    Respir Investig; 2022 Sep; 60(5):674-683. PubMed ID: 35843830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference equation for the incremental shuttle walk test in Japanese adults.
    Itaki M; Kozu R; Tanaka K; Senjyu H; ;
    Respir Investig; 2018 Nov; 56(6):497-502. PubMed ID: 30392537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of non-tuberculous mycobacterial pulmonary diseases in patients with mechanical ventilation].
    Yang C; Chen S; Xi Y; Liu D; Zhang R; Qiu G; He W; Li Y; Liu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):1033-1036. PubMed ID: 31537234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional exercise capacity in patients with ankylosing spondylitis.
    Acar Y; İlçin N; Sarı IS; Önen F
    Physiother Theory Pract; 2023 Sep; ():1-7. PubMed ID: 37776295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.